| Michael L Mahoney, MD | |
|
320 East Second Street, Libby, MT 59923 | |
| (406) 293-3755 | |
| (406) 293-6622 |
| Full Name | Michael L Mahoney |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 320 East Second Street, Libby, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588766273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11064 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael L Mahoney, MD 320 East Second Street, Libby, MT 59923 Ph: (406) 293-3755 | Michael L Mahoney, MD 320 East Second Street, Libby, MT 59923 Ph: (406) 293-3755 |
News Archive
Research from University of South Carolina associate professor Saurabh Chatterjee's laboratory in Environmental Health Sciences, Arnold School of Public Health, and led by Ayan Mondal, a postdoctoral researcher from the same lab, has revealed the cause behind the previously established link between non-alcoholic fatty liver disease (i.e., NAFLD, recently reclassified as metabolic associated fatty liver disease or MAFLD) and neurological problems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an acute migraine therapy that is not contraindicated in patients with a history, symptoms or signs of vascular disease and also offers improved efficacy and fast-acting oral delivery would earn a 45 percent patient share in the treatment of migraine, according to surveyed U.S. neurologists.
Newron Pharmaceuticals S.p.A., a research and development company focused on novel CNS and pain therapies, and its commercial and development partner Zambon S.p.A., an international pharmaceutical company, announced today that the NDA for safinamide has been re-submitted to the US FDA.
A recent, clinically-confirmed study has shown that persons suffering from type-2 diabetes have an increased risk of developing colorectal cancer (CRC) when compared to the general public.
Pay-for-performance incentives have been proposed as a method to improve the quality of care received by patients.
› Verified 4 days ago
Jana M Hall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 E 2nd St, Libby, MT 59923 Phone: 406-283-6900 Fax: 406-293-6622 | |
Daniel Williams, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 E 2nd St, Libby, MT 59923 Phone: 406-283-6919 | |
Clyde Allen Knecht, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 403 Utah Ave, Libby, MT 59923 Phone: 406-293-8321 Fax: 406-293-8584 | |
Dr. Mark S Heppe, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 E 3rd St, Libby, MT 59923 Phone: 406-293-9274 Fax: 406-293-9280 | |
Charles Brad Black, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 214 E 3rd St, Libby, MT 59923 Phone: 406-293-9274 Fax: 406-293-9280 | |
Dr. Jane Pauline Borish, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Louisiana Ave, Libby, MT 59923 Phone: 406-293-0133 | |
Samantha Lynn Pyle, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 E 2nd St, Libby, MT 59923 Phone: 406-283-6900 Fax: 406-293-6622 |